Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Futures
Economy
Global Metrics

Celldex Therapeutics Current Ratio 2006-2020 | CLDX

Celldex Therapeutics current ratio from 2006 to 2020. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
  
Celldex Therapeutics Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2020-06-30 $0.21B $0.01B 19.28
2020-03-31 $0.06B $0.01B 5.12
2019-12-31 $0.07B $0.01B 5.73
2019-09-30 $0.08B $0.01B 6.32
2019-06-30 $0.08B $0.01B 7.33
2019-03-31 $0.09B $0.01B 7.41
2018-12-31 $0.10B $0.01B 7.86
2018-09-30 $0.11B $0.02B 6.59
2018-06-30 $0.12B $0.02B 6.02
2018-03-31 $0.13B $0.02B 5.45
2017-12-31 $0.15B $0.03B 5.22
2017-09-30 $0.15B $0.03B 5.91
2017-06-30 $0.16B $0.03B 5.56
2017-03-31 $0.17B $0.03B 6.42
2016-12-31 $0.20B $0.04B 5.55
2016-09-30 $0.21B $0.02B 11.26
2016-06-30 $0.23B $0.02B 11.44
2016-03-31 $0.26B $0.03B 10.31
2015-12-31 $0.30B $0.03B 9.75
2015-09-30 $0.31B $0.02B 13.09
2015-06-30 $0.34B $0.03B 12.72
2015-03-31 $0.36B $0.02B 17.22
2014-12-31 $0.21B $0.02B 8.37
2014-09-30 $0.23B $0.02B 10.63
2014-06-30 $0.26B $0.02B 12.06
2014-03-31 $0.28B $0.02B 14.19
2013-12-31 $0.31B $0.02B 15.00
2013-09-30 $0.14B $0.02B 8.33
2013-06-30 $0.16B $0.01B 12.51
2013-03-31 $0.18B $0.02B 10.06
2012-12-31 $0.09B $0.02B 4.81
2012-09-30 $0.08B $0.02B 5.21
2012-06-30 $0.08B $0.01B 6.39
2012-03-31 $0.09B $0.01B 7.51
2011-12-31 $0.06B $0.01B 3.83
2011-09-30 $0.06B $0.01B 5.97
2011-06-30 $0.07B $0.01B 7.04
2011-03-31 $0.05B $0.01B 5.18
2010-12-31 $0.06B $0.02B 3.12
2010-09-30 $0.06B $0.02B 2.54
2010-06-30 $0.07B $0.02B 2.88
2010-03-31 $0.08B $0.03B 3.15
2009-12-31 $0.08B $0.01B 5.83
2009-09-30 $0.03B $0.01B 1.99
2009-06-30 $0.03B $0.01B 2.61
2009-03-31 $0.04B $0.01B 2.98
2008-12-31 $0.05B $0.01B 3.34
2008-09-30 $0.06B $0.02B 3.02
2008-06-30 $0.07B $0.02B 3.43
2008-03-31 $0.02B $0.01B 1.98
2007-12-31 $0.01B $0.01B 0.56
2007-09-30 $0.02B $0.01B 2.44
2007-06-30 $0.03B $0.01B 3.23
2007-03-31 $0.03B $0.01B 3.32
2006-12-31 $0.04B $0.01B 4.21
2006-09-30 $0.05B $0.01B 5.85
2006-06-30 $0.06B $0.01B 8.34
2006-03-31 $0.06B $0.01B 9.40
2005-12-31 $0.03B $0.00B 6.66
2005-09-30 $0.03B $0.00B 7.97
2005-06-30 $0.03B $0.00B 9.25
2005-03-31 $0.03B $0.01B 6.28
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.506B $0.004B
CELLDEX THERAPEUTICS is an integrated biopharmaceutical company that applies its comprehensive Precision Targeted Immunotherapy Platform to generate a pipeline of candidates to treat cancer and other difficult-to-treat diseases. Celldex's immunotherapy platform includes a complementary portfolio of monoclonal antibodies, antibody-targeted vaccines and immunomodulators to create novel disease-specific drug candidates.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $145.088B 15.76
Bristol Myers Squibb (BMY) United States $134.110B 10.33
CSL (CSLLY) Australia $93.977B 0.00
Gilead Sciences (GILD) United States $81.555B 11.74
Vertex Pharmaceuticals (VRTX) United States $69.125B 38.57
Regeneron Pharmaceuticals (REGN) United States $59.073B 22.59
Biogen (BIIB) United States $43.454B 7.44
Illumina (ILMN) United States $43.143B 50.17
Seattle Genetics (SGEN) United States $31.483B 0.00
Moderna (MRNA) United States $27.570B 0.00
Genmab (GMAB) Denmark $25.300B 15.98
Alexion Pharmaceuticals (ALXN) United States $24.924B 10.39
BeiGene (BGNE) Cayman Islands $24.766B 0.00
Genmab (GNMSF) Denmark $23.997B 5.53
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $21.148B 0.00
Immunomedics (IMMU) United States $19.770B 0.00
Incyte (INCY) United States $18.981B 0.00
Horizon Therapeutics Public (HZNP) Ireland $16.502B 38.61
Alnylam Pharmaceuticals (ALNY) United States $15.338B 0.00
BioNTech SE (BNTX) Germany $15.160B 0.00
Bio-Rad Laboratories (BIO.B) United States $15.059B 68.11
BioMarin Pharmaceutical (BMRN) United States $14.396B 104.45
ARGENX SE-ADR (ARGX) Netherlands $11.740B 0.00
Exact Sciences (EXAS) United States $11.633B 0.00
QIAGEN (QGEN) Netherlands $11.522B 29.24
Sarepta Therapeutics (SRPT) United States $11.346B 0.00
Guardant Health (GH) United States $10.191B 0.00
Bio-Techne Corp (TECH) United States $9.404B 64.52
Galapagos (GLPG) Belgium $9.087B 32.92
Exelixis (EXEL) United States $8.281B 30.11
SWEDISH ORP BIO (BIOVF) Sweden $7.799B 19.40
Ascendis Pharma (ASND) Denmark $7.768B 0.00
Repligen (RGEN) United States $7.665B 121.66
MyoKardia (MYOK) United States $7.238B 0.00
Mirati Therapeutics (MRTX) United States $7.175B 0.00
ACADIA Pharmaceuticals (ACAD) United States $6.689B 0.00
Novavax (NVAX) United States $6.640B 0.00
Acceleron Pharma (XLRN) United States $6.383B 0.00
Adaptive Biotechnologies (ADPT) United States $6.294B 0.00
Momenta Pharmaceuticals (MNTA) United States $6.220B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $6.028B 186.74
Emergent Biosolutions (EBS) United States $5.324B 21.09
Ultragenyx Pharmaceutical (RARE) United States $5.021B 0.00
Zai Lab (ZLAB) China $4.606B 0.00
MorphoSys AG (MOR) Germany $4.503B 59.02
China Biologic Products (CBPO) China $4.408B 26.16
Blueprint Medicines (BPMC) United States $4.391B 0.00
Vir Biotechnology (VIR) United States $4.157B 0.00
Legend Biotech (LEGN) United States $4.136B 0.00
Arena Pharmaceuticals (ARNA) United States $4.107B 0.00
Denali Therapeutics (DNLI) United States $4.092B 0.00
NeoGenomics (NEO) United States $3.957B 1194.33
Halozyme Therapeutics (HALO) United States $3.801B 0.00
Amicus Therapeutics (FOLD) United States $3.778B 0.00
Bluebird Bio (BLUE) United States $3.752B 0.00
Reata Pharmaceuticals (RETA) United States $3.545B 0.00
Fate Therapeutics (FATE) United States $3.409B 0.00
Global Blood Therapeutics (GBT) United States $3.395B 0.00
Insmed (INSM) United States $3.386B 0.00
Principia Biopharma (PRNB) United States $3.330B 0.00
Deciphera Pharmaceuticals (DCPH) United States $3.161B 0.00
Twist Bioscience (TWST) United States $3.029B 0.00
Alkermes (ALKS) Ireland $2.868B 60.10
Inovio Pharmaceuticals (INO) United States $2.848B 0.00
PHARMA MAR SA (PHMMF) Spain $2.290B 0.00
Sorrento Therapeutics (SRNE) United States $2.282B 0.00
Intra-Cellular Therapies (ITCI) United States $2.117B 0.00
Editas Medicine (EDIT) United States $2.111B 0.00
Revance Therapeutics (RVNC) United States $2.106B 0.00
Mesoblast (MESO) Australia $2.098B 0.00
I-Mab (IMAB) China $2.092B 0.00
Zymeworks (ZYME) Canada $2.069B 0.00
Eidos Therapeutics (EIDX) United States $2.034B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $2.006B 22.47
Seres Therapeutics (MCRB) United States $1.956B 0.00
Forma Therapeutics Holdings (FMTX) United States $1.862B 0.00
UniQure (QURE) Netherlands $1.853B 0.00
Akcea Therapeutics (AKCA) United States $1.844B 0.00
Viela Bio (VIE) United States $1.628B 0.00
Amarin (AMRN) Ireland $1.607B 0.00
Cytokineticsorporated (CYTK) United States $1.537B 0.00
Sangamo Therapeutics (SGMO) United States $1.525B 0.00
Beam Therapeutics (BEAM) United States $1.524B 0.00
Mersana Therapeutics (MRSN) United States $1.509B 0.00
Ligand Pharmaceuticals (LGND) United States $1.480B 50.04
Dicerna Pharmaceuticals (DRNA) United States $1.478B 0.00
Zealand Pharma (ZEAL) Denmark $1.451B 0.00
Arcus Biosciences (RCUS) United States $1.424B 0.00
Coherus BioSciences (CHRS) United States $1.422B 8.29
Intercept Pharmaceuticals (ICPT) United States $1.382B 0.00
Intellia Therapeutics (NTLA) United States $1.381B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $1.357B 0.00
Epizyme (EPZM) United States $1.346B 0.00
Zealand Pharma (ZLDPF) Denmark $1.339B 0.00
NGM Biopharmaceuticals (NGM) United States $1.317B 0.00
Compugen (CGEN) Israel $1.290B 0.00
Alcobra (ARCT) United States $1.144B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.137B 0.00
REGENXBIO (RGNX) United States $1.118B 0.00
Alector (ALEC) United States $1.115B 0.00
Arvinas (ARVN) United States $1.098B 0.00
Athenex (ATNX) United States $1.073B 0.00
Retrophin (RTRX) United States $1.031B 0.00
Castle Biosciences (CSTL) United States $1.005B 0.00
Pliant Therapeutics (PLRX) United States $1.000B 0.00
Adverum Biotechnologies (ADVM) United States $0.999B 0.00
Myriad Genetics (MYGN) United States $0.966B 0.00
Agenus (AGEN) United States $0.950B 0.00
Heska (HSKA) United States $0.933B 0.00
NantKwest (NK) United States $0.917B 0.00
Morphic Holding (MORF) United States $0.885B 0.00
Cellectis S.A (CLLS) France $0.885B 0.00
Vericel (VCEL) United States $0.865B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.842B 0.00
Frequency Therapeutics (FREQ) United States $0.840B 0.00
VBI Vaccines (VBIV) United States $0.828B 0.00
Intrexon (PGEN) United States $0.810B 0.00
Protagonist Therapeutics (PTGX) United States $0.810B 0.00
Kadmon Holdings (KDMN) United States $0.770B 0.00
Codexis (CDXS) United States $0.720B 0.00
MiMedx (MDXG) United States $0.715B 0.00
Pharming Group (PHGUF) Netherlands $0.714B 16.29
WAVE Life Sciences (WVE) Singapore $0.712B 0.00
Cara Therapeutics (CARA) United States $0.681B 0.00
Northwest Biotherapeutics (NWBO) United States $0.670B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.656B 0.00
AC Immune SA (ACIU) Switzerland $0.644B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.642B 0.00
Sinovac Biotech (SVA) China $0.640B 43.13
Clovis Oncology (CLVS) United States $0.614B 0.00
Geron (GERN) United States $0.609B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.596B 0.00
Dynavax Technologies (DVAX) United States $0.595B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.591B 0.00
Albireo Pharma (ALBO) United States $0.583B 0.00
Aquinox Pharmaceuticals (NLTX) United States $0.580B 0.00
IVERIC Bio (ISEE) United States $0.563B 0.00
Forte Biosciences (FBRX) United States $0.555B 0.00
Kala Pharmaceuticals (KALA) United States $0.551B 0.00
Scholar Rock Holding (SRRK) United States $0.543B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.538B 4.71
Anika Therapeutics (ANIK) United States $0.519B 22.70
Cue Biopharma (CUE) United States $0.510B 0.00
MeiraGTx Holdings (MGTX) United States $0.506B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.503B 0.00
MannKind (MNKD) United States $0.477B 0.00
UROGEN PHARMA (URGN) United States $0.470B 0.00
Syros Pharmaceuticals (SYRS) United States $0.458B 0.00
Starpharma Holdings (SPHRY) Australia $0.457B 0.00
Avid Bioservices (CDMO) United States $0.449B 0.00
AnaptysBio (ANAB) United States $0.439B 0.00
Athersys (ATHX) United States $0.430B 0.00
Sutro Biopharma (STRO) United States $0.426B 0.00
Prothena (PRTA) Ireland $0.425B 0.00
Fortress Biotech (FBIO) United States $0.421B 0.00
Amryt Pharma (AMYT) United Kingdom $0.414B 0.00
Puma Biotechnology (PBYI) United States $0.411B 0.00
BioDelivery Sciences (BDSI) United States $0.411B 29.07
Xenon Pharmaceuticals (XENE) Canada $0.400B 0.00
Kamada (KMDA) Israel $0.390B 18.66
PDL BioPharma (PDLI) United States $0.380B 0.00
Merus (MRUS) Netherlands $0.376B 0.00
ANI Pharmaceuticals (ANIP) United States $0.374B 8.83
Cellular Biomedicine (CBMG) United States $0.363B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.351B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.351B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.349B 0.00
Trevena (TRVN) United States $0.342B 0.00
CytomX Therapeutics (CTMX) United States $0.342B 0.00
Precision BioSciences (DTIL) United States $0.311B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.304B 0.00
Innate Pharma S.A (IPHA) France $0.302B 0.00
Affimed (AFMD) Germany $0.290B 0.00
Cyclerion Therapeutics (CYCN) United States $0.285B 0.00
Prometic Life Sciences (LMNL) Canada $0.282B 0.00
OSMOTICA PHARM (OSMT) United States $0.281B 0.00
Selecta Biosciences (SELB) United States $0.279B 0.00
ChromaDex (CDXC) United States $0.275B 0.00
NextCure (NXTC) United States $0.263B 0.00
Arbutus Biopharma (ABUS) United States $0.260B 0.00
Pluristem Therapeutics (PSTI) Israel $0.258B 0.00
HOOKIPA Pharma (HOOK) United States $0.240B 0.00
Verastem (VSTM) United States $0.236B 0.00
Aduro Biotech (ADRO) United States $0.224B 0.00
TELA Bio (TELA) United States $0.222B 0.00
Dyadic (DYAI) United States $0.222B 0.00
Liquidia Technologies (LQDA) United States $0.219B 0.00
XOMA (XOMA) United States $0.218B 0.00
DBV Technologies S.A (DBVT) France $0.214B 0.00
Spero Therapeutics (SPRO) United States $0.214B 0.00
Kindred Biosciences (KIN) United States $0.208B 0.00
Cerecor (CERC) United States $0.208B 0.00
ADMA Biologics Inc (ADMA) United States $0.206B 0.00
Checkpoint Therapeutics (CKPT) United States $0.204B 0.00
Cardiff Oncology (CRDF) United States $0.202B 0.00
Theratechnologies (THTX) Canada $0.201B 0.00
Biofrontera AG (BFRA) Germany $0.200B 0.00
Eton Pharmaceuticals (ETON) United States $0.190B 0.00
POXEL SA FRANCE (PXXLF) France $0.188B 0.00
GENFIT S.A (GNFT) France $0.179B 0.00
Exicure (XCUR) United States $0.179B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.177B 0.00
Abeona Therapeutics (ABEO) United States $0.176B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.174B 8.10
Aytu Bioscience (AYTU) United States $0.166B 0.00
AquaBounty Technologies (AQB) United States $0.166B 0.00
Aptinyx (APTX) United States $0.163B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.161B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.155B 0.00
Nicox SA (NICXF) France $0.149B 0.00
SESEN BIO, INC (SESN) United States $0.148B 0.00
Five Prime Therapeutics (FPRX) United States $0.148B 0.00
VTv Therapeutics (VTVT) United States $0.147B 0.00
Bellus Health (BLU) Canada $0.147B 0.00
Applied Genetic Technologies (AGTC) United States $0.141B 0.00
Celyad SA (CYAD) Belgium $0.136B 0.00
Cidara Therapeutics (CDTX) United States $0.134B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.134B 0.00
Gritstone Oncology (GRTS) United States $0.125B 0.00
Lumos Pharma (LUMO) United States $0.121B 0.00
Strongbridge Biopharma (SBBP) United States $0.120B 0.00
Orgenesis (ORGS) United States $0.118B 6.02
Vaccinex (VCNX) United States $0.114B 0.00
Unum Therapeutics (UMRX) United States $0.112B 0.00
Windtree Therapeutics (WINT) United States $0.112B 0.00
Enzo Biochem (ENZ) United States $0.111B 0.00
PHASEBIO PHARMA (PHAS) United States $0.107B 0.00
Antibe Therapeutics (ATBPF) Canada $0.107B 0.00
Catalyst Biosciences (CBIO) United States $0.106B 0.00
ARAVIVE, INC (ARAV) United States $0.100B 0.00
AIT Therapeutics (XAIR) United States $0.098B 0.00
Idera Pharmaceuticals (IDRA) United States $0.094B 0.00
Oncobiologics (OTLK) United States $0.088B 0.00
Bionano Genomics (BNGO) United States $0.085B 0.00
DiaMedica Therapeutics (DMAC) United States $0.082B 0.00
Clearside Biomedical (CLSD) United States $0.080B 0.00
Adocia (ADOCY) France $0.080B 0.00
Evogene (EVGN) Israel $0.080B 0.00
Ecology Coatings (ABVC) United States $0.078B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.074B 0.00
TRACON Pharmaceuticals (TCON) United States $0.074B 0.00
Prima BioMed (IMMP) Australia $0.074B 0.00
Synlogic (SYBX) United States $0.073B 0.00
Edesa Biotech (EDSA) Canada $0.073B 0.00
Proteostasis Therapeutics (PTI) United States $0.066B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.066B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.063B 0.00
Emmaus Life Sciences (EMMA) United States $0.063B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.061B 0.00
Curis (CRIS) United States $0.060B 0.00
Soligenix (SNGX) United States $0.060B 0.00
Vascular Biogenics (VBLT) Israel $0.055B 0.00
AnPac Bio-Medical Science (ANPC) China $0.054B 0.00
Stealth BioTherapeutics (MITO) United States $0.053B 76.25
Appili Therapeutics (APLIF) Canada $0.052B 0.00
Cocrystal Pharma (COCP) United States $0.052B 0.00
Happiness Biotech Group (HAPP) China $0.051B 0.00
Genetic Technologies (GENE) Australia $0.051B 0.00
Novogen (KZIA) Australia $0.049B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.049B 0.00
Signal Genetics (MGEN) United States $0.048B 0.00
Organovo Holdings (ONVO) United States $0.047B 0.00
CollPlant Holdings (CLGN) Israel $0.047B 0.00
IMMURON (IMRN) Australia $0.045B 0.00
Pulmatrix (PULM) United States $0.044B 0.00
ATyr Pharma (LIFE) United States $0.041B 0.00
Chanticleer Holdings (SONN) United States $0.038B 0.00
Prana Biotechnology (ATHE) Australia $0.033B 0.00
OvaScience (MLND) United States $0.031B 0.00
BioCardia (BCDA) United States $0.030B 0.00
Apricus Biosciences (SEEL) United States $0.030B 0.00
Advaxis (ADXS) United States $0.029B 0.00
Alimera Sciences (ALIM) United States $0.029B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.028B 0.00
Cleveland BioLabs (CBLI) United States $0.027B 0.00
Celsion (CLSN) United States $0.026B 0.00
Acorda Therapeutics (ACOR) United States $0.026B 0.00
Aptevo Therapeutics (APVO) United States $0.025B 0.00
Cesca Therapeutics (THMO) United States $0.024B 0.00
Spherix (AIKI) United States $0.021B 0.00
Titan Pharmaceuticals (TTNP) United States $0.020B 0.00
AEterna Zentaris (AEZS) United States $0.020B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.018B 0.00
MYOS RENS Technology (MYOS) United States $0.018B 0.00
Neuralstem (SNCA) United States $0.010B 0.00
Benitec Biopharma (BNTC) Australia $0.008B 0.00
Entera Bio (ENTX) Israel $0.000B 0.00